RXDS Trademark

Trademark Overview

On Wednesday, June 28, 2017, a trademark application was filed for RXDS with the United States Patent and Trademark Office. The USPTO has given the RXDS trademark a serial number of 87508988. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, October 3, 2025. This trademark is owned by RxDataScience, Inc.. The RXDS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Software as a service (SAAS) services featuring software for use in analytics and data analysis for the healthcare and pharmaceutical industries
rxds

General Information

Serial Number87508988
Word MarkRXDS
Filing DateWednesday, June 28, 2017
Status710 - CANCELLED - SECTION 8
Status DateFriday, October 3, 2025
Registration Number5704067
Registration DateTuesday, March 19, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 8, 2018

Trademark Statements

Goods and ServicesSoftware as a service (SAAS) services featuring software for use in analytics and data analysis for the healthcare and pharmaceutical industries

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, October 3, 2025
Primary Code042
First Use Anywhere DateThursday, August 27, 2015
First Use In Commerce DateMonday, September 7, 2015

Trademark Owner History

Party NameRxDataScience, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 10006
Party NameRxDataScience, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10006
Party NameRxDataScience, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10006

Trademark Events

Event DateEvent Description
Monday, September 18, 2017ASSIGNED TO EXAMINER
Saturday, July 1, 2017NEW APPLICATION ENTERED
Thursday, July 6, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 19, 2017NON-FINAL ACTION WRITTEN
Tuesday, September 19, 2017NON-FINAL ACTION E-MAILED
Tuesday, September 19, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 19, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 19, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 20, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 2, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 18, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 8, 2018PUBLISHED FOR OPPOSITION
Tuesday, May 8, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 3, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, July 30, 2018TEAS STATEMENT OF USE RECEIVED
Monday, July 30, 2018USE AMENDMENT FILED
Tuesday, August 28, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, September 14, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 28, 2018STATEMENT OF USE PROCESSING COMPLETE
Friday, September 14, 2018SU - NON-FINAL ACTION - WRITTEN
Friday, September 14, 2018NON-FINAL ACTION E-MAILED
Tuesday, January 29, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, February 2, 2019ASSIGNED TO LIE
Friday, February 8, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 8, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, February 9, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, February 12, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, March 19, 2019REGISTERED-PRINCIPAL REGISTER
Sunday, May 19, 2019TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Wednesday, October 4, 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Sunday, May 19, 2019WITHDRAWAL OF ATTORNEY GRANTED
Tuesday, March 19, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, October 3, 2025CANCELLED SEC. 8 (6-YR)

Related Keywords

rxds software analysis healthcare pharmaceutical industries data analytics service saas services